Dysglycemia
48
5
10
21
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
1 terminated out of 48 trials
95.5%
+8.9% vs benchmark
10%
5 trials in Phase 3/4
10%
2 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (48)
Accuracy of Continuous Glucose Monitoring in Patients With Diabetes. A Prospective Observational Study
The Effect of Continuous Glucose Monitoring in Surgical Patients With Diabetes.
Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome
Effects of Habitual Water Intake on Thirst in Healthy Young Adults Explained by Osmoadaptive Metabolism, Brain and Kidney Function (Adapt-Thirst)
Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
Effect of a Food Supplement on Blood Glucose Levels in Patients With Impaired Glucose Values
Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia
Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk
Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)
Polish Registry of Diabetes (PolReD)
Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients
The Soy Treatment Evaluation for Metabolic Health (STEM) Trial
Snus and Home Blood Pressure
Effect of the Association of Berberine Fitosoma® and Monacolin K MonaKoPure® on Glyco-metabolic Parameters in Dysglycemic and Dyslipidemic Patients.
Electronic Clinical Decision Support for Diabetes and Dysglycaemia in Secondary Mental Healthcare
Study to Assess the Effects of Non Digestible Carbohydrates on Long-Term Glucose Homeostasis in Untreated Prediabetic Subjects
Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk
Alcohol & Metabolic Comorbidities in PLWHA: Evidence Driven Interventions
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)